Nature Biotechnology
Close windowclose window
Figure 4

Nature Biotechnology 24, 509 - 515 (2006)
doi:10.1038/nbt0506-509

Gold in the ivory tower: equity rewards of outlicensing

Mark Edwards, Fiona Murray & Robert Yu

 
Fig 4 full size
Figure 4. Momenta Pharmaceuticals valuation history.
 
Previous | Next 
Close windowclose window
©2007 Nature Publishing Group | Privacy policy